MedTrace Logo

HIV and HCV Intervention In Drug Treatment Settings - 1

NCT00102349 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 706

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Conditions

  • Behavior Therapy

Interventions

BEHAVIORAL

Behavior Therapy

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Robert Booth, Ph.D. · University of Colorado, Denver

Study Design

Purpose
PREVENTION

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102349 on ClinicalTrials.gov